Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature

While margin-negative resection remains the cornerstone of therapy for retroperitoneal sarcoma (RPS), the impact of adjuvant chemotherapy (AC) on overall survival (OS) remains poorly understood.

Source: Surgical Oncology - January 31, 2017 Category: Surgery Authors: Jashodeep Datta, Brett L. Ecker, Madalyn G. Neuwirth, Rula C. Geha, Douglas L. Fraker, Robert E. Roses, Giorgos C. Karakousis Source Type: research